Clinical Edge Journal Scan

Concurrent onset of skin and joint symptoms tied to high disease activity in PsA


 

Key clinical point: Concurrent onset of skin lesions and joint symptoms increased the likelihood of moderate or high disease activity in patients with psoriatic arthritis (PsA), highlighting the importance of sequence in which skin and joint symptoms appear in disease management.

Major finding: Patients with concurrent onset of skin and joint symptoms (adjusted odds ratio 4.65; P = .007) were more likely to have a moderate or high disease activity (Psoriatic Arthritis Disease Activity Score >3.2).

Study details: Findings are from a retrospective cross-sectional study including 286 patients with PsA.

Disclosures: This study was funded by the National Natural Science Foundation of China. No conflicts of interest were declared.

Source: Tan M et al. Concurrent onset of skin and joint symptoms correlates with higher psoriatic arthritis disease activity: A single-center retrospective study. J Am Acad Dermatol . 2023 (Mar 6). Doi: 10.1016/j.jaad.2023.02.045

Recommended Reading

Commentary: Concerning PsA treatments and comorbidities, March 2023
MDedge Rheumatology
Biologics show signs of delaying arthritis in psoriasis patients
MDedge Rheumatology
Psoriatic arthritis treatment for women falls short, study suggests
MDedge Rheumatology
Gender-based differences in treatment outcomes and persistence with ustekinumab or TNFi in PsA
MDedge Rheumatology
Achievement of low disease activity improves long-term structural damage in PsA
MDedge Rheumatology
Active disease in third trimester increases risk for emergency caesarean section in PsA
MDedge Rheumatology
Guselkumab resolves dactylitis and improves clinical outcomes in patients with active PsA
MDedge Rheumatology
JAKi effective for PsA but higher doses may have increased toxicity
MDedge Rheumatology
Real world study finds no evidence of increased cancer risk with JAKi vs TNFi in PsA
MDedge Rheumatology
Ultrasound helps screen patients with moderate-to-severe psoriasis progressing to subclinical PsA
MDedge Rheumatology